Trial Profile
Efficacy of Cabergoline in Japanese Patients with Sporadic Acromegaly and AIP Gene Mutations
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Acromegaly; Pituitary adenoma
- Focus Therapeutic Use
- 24 Aug 2015 New trial record